Specialist pharmaceutical firm Vectura, which has its roots in a spin-out from the University of Bath, has agreed to be taken over by global private equity giant Carlyle for £958m. The approach by Carlyle has been approved by Vectura’s board. Chairman Bruno Angelici said while the firm’s directors remained confident in its long-term fundamentals,...